Modulation of microglia activation by the ascorbic acid transporter SVCT2
-
Published:2024-08
Issue:
Volume:120
Page:557-570
-
ISSN:0889-1591
-
Container-title:Brain, Behavior, and Immunity
-
language:en
-
Short-container-title:Brain, Behavior, and Immunity
Author:
Marino Amanda L., Rex Tonia S., Harrison Fiona E.ORCID
Reference84 articles.
1. Aguzzi, A., Barres, B.A. and Bennett, M.L. (2013) ‘Microglia: Scapegoat, Saboteur, or Something Else?’, Science, 339(6116), pp. 156–161. Available at: https://doi.org/10.1126/science.1227901. 2. Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment;Arciniegas;Neuropsychiatr. Dis. Treat.,2005 3. Batista, C.R.A. et al. (2019) ‘Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration’, International Journal of Molecular Sciences, 20(9), p. 2293. Available at: https://doi.org/10.3390/ijms20092293. 4. Berger, U.V. et al. (2003) ‘Effect of middle cerebral artery occlusion on mRNA expression for the sodium-coupled vitamin C transporter SVCT2 in rat brain: Ascorbate transporter expression after ischemia’, Journal of Neurochemistry, 86(4), pp. 896–906. Available at: https://doi.org/10.1046/j.1471-4159.2003.01891.x. 5. Bolte, A.C. and Lukens, J.R. (2021) ‘Neuroimmune cleanup crews in brain injury’, Trends in Immunology, p. S1471490621000740. Available at: https://doi.org/10.1016/j.it.2021.04.003.
|
|